Search

John Eric Hug

Examiner (ID: 208, Phone: (571)272-1192 , Office: P/1741 )

Most Active Art Unit
1731
Art Unit(s)
1741, 1791, 1731, 1748
Total Applications
1588
Issued Applications
1319
Pending Applications
41
Abandoned Applications
236

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9875530 [patent_doc_number] => 08962796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Modified variant Bowman Birk protease inhibitors' [patent_app_type] => utility [patent_app_number] => 13/756337 [patent_app_country] => US [patent_app_date] => 2013-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 32 [patent_no_of_words] => 118693 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 292 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13756337 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/756337
Modified variant Bowman Birk protease inhibitors Jan 30, 2013 Issued
Array ( [id] => 8892209 [patent_doc_number] => 20130165393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'PHOSPHOLIPID AND PROTEIN TABLETS' [patent_app_type] => utility [patent_app_number] => 13/748013 [patent_app_country] => US [patent_app_date] => 2013-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27682 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13748013 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/748013
PHOSPHOLIPID AND PROTEIN TABLETS Jan 22, 2013 Abandoned
Array ( [id] => 9793536 [patent_doc_number] => 20150005480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'Affinity Tag System' [patent_app_type] => utility [patent_app_number] => 14/369331 [patent_app_country] => US [patent_app_date] => 2013-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10748 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369331 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/369331
Affinity tag system Jan 6, 2013 Issued
Array ( [id] => 8822459 [patent_doc_number] => 20130123504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'PHARMACOLOGICALLY ACTIVE COMPOUNDS CONTAINING SULFUR' [patent_app_type] => utility [patent_app_number] => 13/734270 [patent_app_country] => US [patent_app_date] => 2013-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8166 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734270 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/734270
Pharmacologically active compounds containing sulfur Jan 3, 2013 Issued
Array ( [id] => 10968105 [patent_doc_number] => 20140371139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE' [patent_app_type] => utility [patent_app_number] => 14/365841 [patent_app_country] => US [patent_app_date] => 2012-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3389 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14365841 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/365841
Preparations containing amorphous emodepside Dec 17, 2012 Issued
Array ( [id] => 9204917 [patent_doc_number] => 20140004094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/713019 [patent_app_country] => US [patent_app_date] => 2012-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 42683 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13713019 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/713019
COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES Dec 12, 2012 Abandoned
Array ( [id] => 9538289 [patent_doc_number] => 20140162937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'POLYMYXIN DERIVATIVES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/709657 [patent_app_country] => US [patent_app_date] => 2012-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26182 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13709657 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/709657
Polymyxin derivatives and uses thereof Dec 9, 2012 Issued
Array ( [id] => 8865618 [patent_doc_number] => 20130149321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'CANDIDATES AGAINST INFECTION' [patent_app_type] => utility [patent_app_number] => 13/685466 [patent_app_country] => US [patent_app_date] => 2012-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21686 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13685466 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/685466
CANDIDATES AGAINST INFECTION Nov 25, 2012 Abandoned
Array ( [id] => 8733715 [patent_doc_number] => 20130079284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'TREATMENT OF T-CELL MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/679599 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9987 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13679599 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/679599
TREATMENT OF T-CELL MEDIATED DISEASES Nov 15, 2012 Abandoned
Array ( [id] => 8720231 [patent_doc_number] => 20130071448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'TREATMENT OF T-CELL MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/676966 [patent_app_country] => US [patent_app_date] => 2012-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9993 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676966 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/676966
Treatment of T-cell mediated diseases Nov 13, 2012 Issued
Array ( [id] => 9882543 [patent_doc_number] => 08969308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Treatment of T-cell mediated diseases' [patent_app_type] => utility [patent_app_number] => 13/676932 [patent_app_country] => US [patent_app_date] => 2012-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10017 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676932 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/676932
Treatment of T-cell mediated diseases Nov 13, 2012 Issued
Array ( [id] => 8721467 [patent_doc_number] => 20130072684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'TREATMENT OF T-CELL MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/677007 [patent_app_country] => US [patent_app_date] => 2012-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9992 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13677007 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/677007
Treatment of T-cell mediated diseases Nov 13, 2012 Issued
Array ( [id] => 8982082 [patent_doc_number] => 08513196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Treatment of T-cell mediated diseases' [patent_app_type] => utility [patent_app_number] => 13/676984 [patent_app_country] => US [patent_app_date] => 2012-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10018 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13676984 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/676984
Treatment of T-cell mediated diseases Nov 13, 2012 Issued
Array ( [id] => 9162261 [patent_doc_number] => 20130310538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES' [patent_app_type] => utility [patent_app_number] => 13/674285 [patent_app_country] => US [patent_app_date] => 2012-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7514 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13674285 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/674285
METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES Nov 11, 2012 Abandoned
Array ( [id] => 8884748 [patent_doc_number] => 20130157932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'NGAL AND URINARY TRACT INFECTION' [patent_app_type] => utility [patent_app_number] => 13/671533 [patent_app_country] => US [patent_app_date] => 2012-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 25711 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13671533 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/671533
NGAL AND URINARY TRACT INFECTION Nov 6, 2012 Abandoned
Array ( [id] => 9786259 [patent_doc_number] => 20140303080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'N-ACYLDIPEPTIDE DERIVATIVES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 14/354711 [patent_app_country] => US [patent_app_date] => 2012-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21081 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354711 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/354711
N-acyldipeptide derivatives and their uses Oct 30, 2012 Issued
Array ( [id] => 8822141 [patent_doc_number] => 20130123186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS' [patent_app_type] => utility [patent_app_number] => 13/664168 [patent_app_country] => US [patent_app_date] => 2012-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17343 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13664168 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/664168
NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS Oct 29, 2012 Abandoned
Array ( [id] => 8671484 [patent_doc_number] => 20130046023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING GLUR2-LACKING AMPAR ANTAGONIST FOR PREVENTING OR TREATING PSYCHIATRIC ILLNESSES' [patent_app_type] => utility [patent_app_number] => 13/658899 [patent_app_country] => US [patent_app_date] => 2012-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2968 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13658899 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/658899
Pharmaceutical composition containing GLUR2-lacking AMPAR antagonist for preventing or treating psychiatric illnesses Oct 23, 2012 Issued
Array ( [id] => 8858653 [patent_doc_number] => 08461188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use' [patent_app_type] => utility [patent_app_number] => 13/655704 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15135 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655704 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/655704
Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use Oct 18, 2012 Issued
Array ( [id] => 8939414 [patent_doc_number] => 20130189211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'Cosmetic Compositions' [patent_app_type] => utility [patent_app_number] => 13/655268 [patent_app_country] => US [patent_app_date] => 2012-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6405 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655268 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/655268
Cosmetic Compositions Oct 17, 2012 Abandoned
Menu